Skip to main content

Table 3 Characteristics of patients present at the ADDO

From: Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment

  Pre-intervention Post-intervention
Subsidized (n = 54) Unsubsidized (n = 46) Control (n = 59) χ 2 p value Subsidized (n = 217) Unsubsidized (n = 247) Control (n = 244) χ 2 p value
Patient age (median, range) 24.5 (1–66) 22 (<1–62) 27 (<1–83)   23 (<1–79) 22 (1–92) 24 (1–74)  
Male (%, 95% CI) 48.1 (34.6–61.7) 47.8 (33.1–62.5) 50.8 (37.8–63.8) 0.941 47.9 (41.2–54.6) 53.0 (46.8–59.3) 50.8 (44.5–57.1) 0.546
Days Ill (median, range) 3 (<1, 14) 3 (<1, 30) 3 (<1, 14)   2 (<1, 60) 3 (<1, 30) 2 (<1, 60)  
ADDO first place treatment sought (%, 95% CI) 70.4 (58.0–82.8) 65.2 (51.2–79.2) 80.0 (69.2–90.1) 0.240 77.4 (71.8–83.0) 74.8 (69.4–80.2) 75.4 (70.0–80.8) 0.792
Malaria test prior to ADDO Visit (%, 95% CI) 16.7 (6.6–26.8) 21.7 (9.6–33.9) 3.4 (0.0–8.1) 0.015 11.1 (6.8–15.4) 13.4 (9.0–17.8) 14.9 (10.2–19.7) 0.502